Effect of interleukin 12 (IL-12) on embryonic development and yolk sac vascularisation

Creative Commons License

NİSARİ M., ÜLGER H., UNUR E., Karaca O., Ertekin T.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.115, sa.9, ss.532-537, 2014 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 115 Sayı: 9
  • Basım Tarihi: 2014
  • Doi Numarası: 10.4149/bll_2014_103
  • Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.532-537
  • Anahtar Kelimeler: interleukin 12, vascularisation, yolk sac, embryo culture, ENDOTHELIAL GROWTH-FACTOR, CD4(+) T-CELLS, IN-VITRO, DENDRITIC CELLS, ANTITUMOR IMMUNITY, IFN-GAMMA, ANGIOGENESIS, THERAPY, RAT, VASCULOGENESIS
  • Erciyes Üniversitesi Adresli: Evet

Özet

Background: In the recent days there has been an increase in diseases known as "angiogenic diseases" characterized by pathologic vascularisation. In the rat, the development of embryonic vessel starts to occur at 9.5 days of gestation. In mammals, the vascular system starts developing in a very early embryonic stage. The majority of rat embryo circulation system gets complete approximately at 11 - 12 days. Therefore the in vitro study of 9.5 - 11.5-day old embryo culture could be a suitable model to study the effects of angiogenic and antiangiogenic substances on yolk sac vascularisation. In the present study, the effects of Interleukin-12 (IL-12) on the yolk sac vascularisation are investigated during the in vitro embryo culture, where the latter angiogenic factor was added to serum.